These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD4 T Cells in McLaughlin TA; Khayumbi J; Ongalo J; Tonui J; Campbell A; Allana S; Gurrion Ouma S; Odhiambo FH; Gandhi NR; Day CL Front Immunol; 2020; 11():127. PubMed ID: 32117277 [No Abstract] [Full Text] [Related]
4. Study of CD27 and CCR4 Markers on Specific CD4 Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J Front Immunol; 2018; 9():3094. PubMed ID: 30687314 [TBL] [Abstract][Full Text] [Related]
5. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection. Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654 [TBL] [Abstract][Full Text] [Related]
7. Activation Phenotype of Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z Front Immunol; 2021; 12():721013. PubMed ID: 34512645 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy. Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C Front Immunol; 2018; 9():2247. PubMed ID: 30323818 [No Abstract] [Full Text] [Related]
11. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N Front Immunol; 2014; 5():180. PubMed ID: 24795723 [TBL] [Abstract][Full Text] [Related]
12. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. Schuetz A; Haule A; Reither K; Ngwenyama N; Rachow A; Meyerhans A; Maboko L; Koup RA; Hoelscher M; Geldmacher C PLoS One; 2011; 6(11):e27284. PubMed ID: 22087280 [TBL] [Abstract][Full Text] [Related]
13. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection. Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147 [TBL] [Abstract][Full Text] [Related]
15. Impact of antiretroviral and tuberculosis therapies on CD4 Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002 [TBL] [Abstract][Full Text] [Related]
16. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia. Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595 [TBL] [Abstract][Full Text] [Related]
17. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis. Petruccioli E; Petrone L; Vanini V; Cuzzi G; Navarra A; Gualano G; Palmieri F; Girardi E; Goletti D J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021 [TBL] [Abstract][Full Text] [Related]
18. CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis. Acharya MP; Pradeep SP; Murthy VS; Chikkannaiah P; Kambar V; Narayanashetty S; Burugina Nagaraja S; Gangadhar N; Yoganand R; Satchidanandam V Clin Infect Dis; 2021 Sep; 73(5):793-801. PubMed ID: 34492697 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the frequency and phenotypic profile of Du Bruyn E; Ruzive S; Howlett P; Jacobs AJ; Arlehamn CSL; Sette A; Sher A; Mayer-Barber KD; Barber DL; Mayosi B; Ntsekhe M; Wilkinson RJ; Riou C Front Immunol; 2022; 13():1009016. PubMed ID: 36439130 [TBL] [Abstract][Full Text] [Related]
20. Potent immune responses of Ag-specific Vgamma2Vdelta2+ T cells and CD8+ T cells associated with latent stage of Mycobacterium tuberculosis coinfection in HIV-1-infected humans. Shao L; Zhang W; Zhang S; Chen CY; Jiang W; Xu Y; Meng C; Weng X; Chen ZW AIDS; 2008 Nov; 22(17):2241-50. PubMed ID: 18981763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]